TY  - JOUR

T1  - Cabozantinib and vandetanib for unresectable locally advanced or metastatic medullary thyroid cancer: a systematic review and economic model

JO  - Health Technology Assessment

UR  - https://eprints.whiterose.ac.uk/143290/

PY  - 2019/03/01

AU  - Tappenden P

AU  - Carroll C

AU  - Hamilton J

AU  - Kaltenthaler E

AU  - Wong R

AU  - Wadsley J

AU  - Moss L

AU  - Balasubramanian S

ED  - 

DO  - DOI: 10.3310/hta23080

VL  - 23

IS  - 8

SP  - 1

EP  - 144

Y2  - 2024/09/20

ER  -